Mutated antigens play a crucial role in the immune system's ability to recognize and destroy cancer cells. Because these antigens are unique to cancer cells, they offer a specific target for immune responses. This specificity makes them ideal targets for cancer immunotherapies, such as [personalized cancer vaccines](), T-cell therapies, and [immune checkpoint inhibitors]().
